What’s the current market cap for Maximus stock?

Maximus (MMS) has a market cap of $3.2bn as of June 17, 2026.

What is the P/E ratio for Maximus stock?

The price to earnings (P/E) ratio for Maximus (MMS) stock is 9.19 as of June 17, 2026.

Does Maximus stock pay dividends?

Yes, the Maximus (MMS) stock pays dividends to shareholders. As of June 17, 2026, the dividend rate is $1.26 and the yield is 2.16%. Maximus has a payout ratio of 18.19% on a trailing twelve-month basis.

When is the next Maximus dividend payment date?

The next Maximus (MMS) dividend payment date is unconfirmed.

What is the beta indicator for Maximus?

Maximus (MMS) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Maximus stock | $MMS Share Price

13:30

15:10

16:45

18:25

20:00

About Maximus

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Ticker

$MMS

Sector

Business services

Primary listing

NYSE

Employees

37,200

Headquarters

McLean, United States

Website

www.maximus.com

Maximus Metrics

BasicAdvanced

$3.2bn

9.19

$6.66

0.60

$1.26

2.16%

What the Analysts think about Maximus

Analyst ratings (Buy, Hold, Sell) for Maximus stock.

Bulls say / Bears say

Maximus raised its full-year FY2026 adjusted diluted earnings per share guidance by $0.20 to a range of $8.25–$8.55 and improved its adjusted EBITDA margin expectation by 20 basis points to approximately 14.2%, reflecting management’s confidence in operational leverage. (Barchart)

Adjusted earnings per share of $2.07 for Q2 FY2026 exceeded the analyst consensus of $2.02, underscoring strong profitability despite modest revenue headwinds. (Investing.com)

Year-to-date signed contract awards totaled $913 million as of March 31, 2026, with an additional $322 million pending, bolstering backlog visibility and future revenue prospects. (Barchart)

Operating cash flow was negative $54.9 million for the six months ended March 31, 2026, driven partly by delayed collections on a large U.S. federal contract, straining working capital and liquidity. (StockTitan)

Quarterly revenue declined to $1.31 billion in Q2 FY2026, down from $1.36 billion a year ago and missing the $1.37 billion consensus, pointing to potential softness in government service demand. (Investing.com)

The Outside the U.S. segment incurred a $3.1 million operating loss in Q2 FY2026, highlighting ongoing challenges and underperformance in international markets. (Barchart)

Data summarised monthly by Lightyear AI. Last updated on 15 Jun 2026.

Maximus Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Maximus Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MMS

Capital at risk

Market closed

Upcoming events

No upcoming events

Bulls say / Bears say

Adjusted earnings per share of $2.07 for Q2 FY2026 exceeded the analyst consensus of $2.02, underscoring strong profitability despite modest revenue headwinds. (Investing.com)

Year-to-date signed contract awards totaled $913 million as of March 31, 2026, with an additional $322 million pending, bolstering backlog visibility and future revenue prospects. (Barchart)

The Outside the U.S. segment incurred a $3.1 million operating loss in Q2 FY2026, highlighting ongoing challenges and underperformance in international markets. (Barchart)

Data summarised monthly by Lightyear AI. Last updated on 15 Jun 2026.